Similar Articles
2141 Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: A multicenter study of 412 patients
2142 Efficacy and safety of thalidomide in patients with hepatocellular carcinoma
2143 Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization
2144 Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma
2145 Chemokine expression in hepatocellular carcinoma versus colorectal liver metastases
2146 Hepatocellular carcinoma metastasizing to the skull base involving multiple cranial nerves
2147 A case of hepatocellular carcinoma arising within large focal nodular hyperplasia with review of the literature
2148 Hepatic intra-arterial infusion of yttrium-90 microspheres in the treatment of recurrent hepatocellular carcinoma after liver transplantation: A case report
2149 Activation of c-Yes in hepatocellular carcinoma: A preliminary study
2150 Evaluation of IGL-1 preservation solution using an orthotopic liver transplantation model
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA